盆腔脂肪瘤病的手术治疗:231 例病例的系统回顾。

IF 2.6 4区 医学 Q2 UROLOGY & NEPHROLOGY Therapeutic Advances in Urology Pub Date : 2023-12-25 eCollection Date: 2023-01-01 DOI:10.1177/17562872231217842
Mancheng Xia, Shengwei Xiong, Zhihua Li, Shubo Fan, Yuke Chen, Liqun Zhou, Kai Zhang, Xuesong Li
{"title":"盆腔脂肪瘤病的手术治疗:231 例病例的系统回顾。","authors":"Mancheng Xia, Shengwei Xiong, Zhihua Li, Shubo Fan, Yuke Chen, Liqun Zhou, Kai Zhang, Xuesong Li","doi":"10.1177/17562872231217842","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pelvic lipomatosis (PL) is a rare condition that is characterized by excessive growth of fat in the pelvic cavity. Studies have yet to systematically review surgical treatments for PL.</p><p><strong>Objectives: </strong>To provide a reference for selecting reasonable surgical treatments for PL patients according to previous literature on the surgical treatment of PL.</p><p><strong>Design and methods: </strong>We conducted this systematic review in accordance with the Preferred Reporting Items for a Systematic Review and Meta-Analysis (PRISMA) of Individual Participant Data guidelines. Literature on PL published from 1968 to 2022 was retrieved from the PubMed and EMBASE databases. Data were collected and analyzed independently by two independent investigators.</p><p><strong>Results: </strong>A total of 42 studies, involving 231 patients with PL, were included in the analysis. The surgical treatments included transurethral resection (TUR) (48.5%), ureteral stent placement (11.7%), percutaneous nephrostomy (1.3%), ureterocutaneostomy (1.3%), ureteral reimplantation (10.4%), ileal conduit (13%), and allograft kidney transplantation (0.4%). After excluding patients with unclear prognoses, 42.9% of patients showed improvement in lower urinary tract symptoms (LUTS) after TUR. Ureteral stent placement provided relief of hydronephrosis in 62.5% of PL patients. Percutaneous nephrostomy resulted in stable renal function in 33.3% of PL patients, while ureterocutaneostomy led to remission of postoperative hydronephrosis in 33.3% of PL patients. After ureteral reimplantation, 70.8% of patients experienced relief of hydronephrosis or had stable renal function. Ileal conduit led to remission of hydronephrosis, alleviation of symptoms, or maintenance of stable renal function in 83.3% of PL patients. One patient with PL had stable renal function after allograft renal transplantation.</p><p><strong>Conclusion: </strong>The surgical treatments for PL include TUR, ureteral stent placement, urinary diversion, and allograft renal transplantation. However, the choice of surgical method should be determined after comprehensive consideration of the patient's condition.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":"15 ","pages":"17562872231217842"},"PeriodicalIF":2.6000,"publicationDate":"2023-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10752117/pdf/","citationCount":"0","resultStr":"{\"title\":\"Surgical treatment of pelvic lipomatosis: a systematic review of 231 cases.\",\"authors\":\"Mancheng Xia, Shengwei Xiong, Zhihua Li, Shubo Fan, Yuke Chen, Liqun Zhou, Kai Zhang, Xuesong Li\",\"doi\":\"10.1177/17562872231217842\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pelvic lipomatosis (PL) is a rare condition that is characterized by excessive growth of fat in the pelvic cavity. Studies have yet to systematically review surgical treatments for PL.</p><p><strong>Objectives: </strong>To provide a reference for selecting reasonable surgical treatments for PL patients according to previous literature on the surgical treatment of PL.</p><p><strong>Design and methods: </strong>We conducted this systematic review in accordance with the Preferred Reporting Items for a Systematic Review and Meta-Analysis (PRISMA) of Individual Participant Data guidelines. Literature on PL published from 1968 to 2022 was retrieved from the PubMed and EMBASE databases. Data were collected and analyzed independently by two independent investigators.</p><p><strong>Results: </strong>A total of 42 studies, involving 231 patients with PL, were included in the analysis. The surgical treatments included transurethral resection (TUR) (48.5%), ureteral stent placement (11.7%), percutaneous nephrostomy (1.3%), ureterocutaneostomy (1.3%), ureteral reimplantation (10.4%), ileal conduit (13%), and allograft kidney transplantation (0.4%). After excluding patients with unclear prognoses, 42.9% of patients showed improvement in lower urinary tract symptoms (LUTS) after TUR. Ureteral stent placement provided relief of hydronephrosis in 62.5% of PL patients. Percutaneous nephrostomy resulted in stable renal function in 33.3% of PL patients, while ureterocutaneostomy led to remission of postoperative hydronephrosis in 33.3% of PL patients. After ureteral reimplantation, 70.8% of patients experienced relief of hydronephrosis or had stable renal function. Ileal conduit led to remission of hydronephrosis, alleviation of symptoms, or maintenance of stable renal function in 83.3% of PL patients. One patient with PL had stable renal function after allograft renal transplantation.</p><p><strong>Conclusion: </strong>The surgical treatments for PL include TUR, ureteral stent placement, urinary diversion, and allograft renal transplantation. However, the choice of surgical method should be determined after comprehensive consideration of the patient's condition.</p>\",\"PeriodicalId\":23010,\"journal\":{\"name\":\"Therapeutic Advances in Urology\",\"volume\":\"15 \",\"pages\":\"17562872231217842\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2023-12-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10752117/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Therapeutic Advances in Urology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/17562872231217842\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Therapeutic Advances in Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/17562872231217842","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:盆腔脂肪瘤病(Pelvic lipomatosis,PL)是一种罕见的疾病,其特点是盆腔内脂肪过度生长。目前尚未有研究对盆腔脂肪瘤的手术治疗方法进行系统回顾:设计与方法:我们根据以往有关盆腔脂肪瘤手术治疗的文献,对盆腔脂肪瘤患者的手术治疗方法进行了系统回顾,为选择合理的手术治疗方法提供参考:我们根据《个人参与者数据系统综述和荟萃分析首选报告项目》(PRISMA)指南进行了此次系统综述。我们从 PubMed 和 EMBASE 数据库中检索了 1968 年至 2022 年发表的有关 PL 的文献。数据由两名独立调查人员独立收集和分析:共有 42 项研究被纳入分析范围,涉及 231 名 PL 患者。手术治疗包括经尿道切除术(TUR)(48.5%)、输尿管支架置入术(11.7%)、经皮肾造瘘术(1.3%)、输尿管造口术(1.3%)、输尿管再植术(10.4%)、回肠导管术(13%)和同种异体肾移植(0.4%)。排除预后不明确的患者后,42.9%的患者在输尿管切开术后下尿路症状(LUTS)有所改善。62.5%的 PL 患者通过输尿管支架置入术缓解了肾积水。33.3% 的 PL 患者通过经皮肾造瘘术获得了稳定的肾功能,而 33.3% 的 PL 患者通过输尿管造口术缓解了术后肾积水。输尿管再植术后,70.8% 的患者肾积水症状缓解或肾功能稳定。83.3% 的 PL 患者通过回肠导管缓解了肾积水、减轻了症状或保持了稳定的肾功能。一名 PL 患者在接受异体肾移植后,肾功能保持稳定:结论:PL 的手术治疗方法包括 TUR、输尿管支架置入术、尿路改道术和异体肾移植。结论:PL 的手术治疗方法包括 TUR、输尿管支架置入术、尿路改道术和异体肾移植,但手术方法的选择应综合考虑患者的病情。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Surgical treatment of pelvic lipomatosis: a systematic review of 231 cases.

Background: Pelvic lipomatosis (PL) is a rare condition that is characterized by excessive growth of fat in the pelvic cavity. Studies have yet to systematically review surgical treatments for PL.

Objectives: To provide a reference for selecting reasonable surgical treatments for PL patients according to previous literature on the surgical treatment of PL.

Design and methods: We conducted this systematic review in accordance with the Preferred Reporting Items for a Systematic Review and Meta-Analysis (PRISMA) of Individual Participant Data guidelines. Literature on PL published from 1968 to 2022 was retrieved from the PubMed and EMBASE databases. Data were collected and analyzed independently by two independent investigators.

Results: A total of 42 studies, involving 231 patients with PL, were included in the analysis. The surgical treatments included transurethral resection (TUR) (48.5%), ureteral stent placement (11.7%), percutaneous nephrostomy (1.3%), ureterocutaneostomy (1.3%), ureteral reimplantation (10.4%), ileal conduit (13%), and allograft kidney transplantation (0.4%). After excluding patients with unclear prognoses, 42.9% of patients showed improvement in lower urinary tract symptoms (LUTS) after TUR. Ureteral stent placement provided relief of hydronephrosis in 62.5% of PL patients. Percutaneous nephrostomy resulted in stable renal function in 33.3% of PL patients, while ureterocutaneostomy led to remission of postoperative hydronephrosis in 33.3% of PL patients. After ureteral reimplantation, 70.8% of patients experienced relief of hydronephrosis or had stable renal function. Ileal conduit led to remission of hydronephrosis, alleviation of symptoms, or maintenance of stable renal function in 83.3% of PL patients. One patient with PL had stable renal function after allograft renal transplantation.

Conclusion: The surgical treatments for PL include TUR, ureteral stent placement, urinary diversion, and allograft renal transplantation. However, the choice of surgical method should be determined after comprehensive consideration of the patient's condition.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
3.70
自引率
0.00%
发文量
39
审稿时长
10 weeks
期刊介绍: Therapeutic Advances in Urology delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of urology. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers in urology, providing a forum in print and online for publishing the highest quality articles in this area. The editors welcome articles of current interest across all areas of urology, including treatment of urological disorders, with a focus on emerging pharmacological therapies.
期刊最新文献
Metaverse surgical planning for robotic surgery: preliminary experience and users' perception. Traumatic ureteral injury: an initial outcome and experience. HoloLens® platform for healthcare professionals simulation training, teaching, and its urological applications: an up-to-date review. Plain Language Summary of Publication: Does crushing vibegron 75 mg tablet affect its safety or the amount of vibegron in the body over time in healthy adults? Comparison of surgical outcomes of endoscopic enucleation of the prostate using different energies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1